The Role of Pre-Clinical 3-Dimensional Models of Osteosarcoma

Int J Mol Sci. 2020 Jul 31;21(15):5499. doi: 10.3390/ijms21155499.

Abstract

Treatment for osteosarcoma (OS) has been largely unchanged for several decades, with typical therapies being a mixture of chemotherapy and surgery. Although therapeutic targets and products against cancer are being continually developed, only a limited number have proved therapeutically active in OS. Thus, the understanding of the OS microenvironment and its interactions are becoming more important in developing new therapies. Three-dimensional (3D) models are important tools in increasing our understanding of complex mechanisms and interactions, such as in OS. In this review, in vivo animal models, in vitro 3D models and in ovo chorioallantoic membrane (CAM) models, are evaluated and discussed as to their contribution in understanding the progressive nature of OS, and cancer research. We aim to provide insight and prospective future directions into the potential translation of 3D models in OS.

Keywords: 3D model; ex vivo; in ovo; in vivo; osteosarcoma.

Publication types

  • Review

MeSH terms

  • Animals
  • Biomarkers, Tumor / genetics
  • Bone Neoplasms / genetics
  • Bone Neoplasms / ultrastructure*
  • Chorioallantoic Membrane / metabolism
  • Chorioallantoic Membrane / ultrastructure*
  • Humans
  • Models, Theoretical*
  • Osteosarcoma / genetics
  • Osteosarcoma / ultrastructure*
  • Prospective Studies
  • Tumor Microenvironment / genetics

Substances

  • Biomarkers, Tumor